Global safety science company Underwriters Laboratories (UL) has acquired Emergo, a privately held firm that provides regulatory services and market access services to medical device manufacturers. The financial details of the acquisition were not disclosed.
The acquisition, announced yesterday, combines UL’s range of services to support global regulatory approvals for the health sciences industry with Emergo’s medical device registration expertise.
“Both UL and Emerge share a common goal to positively impact medical device compliance and safety,” said Upayan Sengupta, VP and general manager of UL’s Health Sciences business, in a press release. “This acquisition provides us with an opportunity to provide medical device manufacturers with value added services as they introduce devices into new markets.”
Since 1997, Emergo has provided regulatory compliance resources and support for its 2,800 clients (medical device and IVD manufacturers) worldwide.
“Medical device regulatory compliance involves keeping up with many moving parts, especially if you’re dealing with more than one market. Many small-to-mid size manufacturers simply lack the resources and expertise to navigate complex regulatory issues,” said Emergo’s CEO Rene van de Zande.
UL has provided safety testing and certification services since 1894 across multiple industries. It has non-clinical testing expertise that includes biocompatibility testing, microbiological and virological testing, cleaning, reprocessing and sterilization, software validation and verification and cybersecurity for medical devices.
Emergo’s Austin, Texas-based headquarters and its more than 200 employees will remain with the company.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]
